COMBINATION BIOLOGIC THERAPY WITH INTERLEUKIN-2 AND INTERFERON-ALFA IN THE OUTPATIENT TREATMENT OF METASTATIC RENAL-CELL CARCINOMA

被引:0
|
作者
FIGLIN, RA [1 ]
PIERCE, WC [1 ]
BELLDEGRUN, A [1 ]
机构
[1] UNIV CALIF LOS ANGELES, SCH MED,JONSSON COMPREHENS CANC CTR,DEPT SURG, DIV UROL, LOS ANGELES, CA 90024 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:11 / 15
页数:5
相关论文
共 50 条
  • [1] INTERLEUKIN-2 AND INTERFERON-ALPHA-2A OUTPATIENT THERAPY FOR METASTATIC RENAL-CELL CARCINOMA
    LIPTON, A
    HARVEY, H
    GIVANT, E
    HOPPER, K
    LAWLER, J
    MATTHEWS, Y
    HIRSH, M
    ZEFFREN, J
    JOURNAL OF IMMUNOTHERAPY, 1993, 13 (02) : 122 - 129
  • [2] COMBINATION OF INTERLEUKIN-2 AND GAMMA-INTERFERON IN METASTATIC RENAL-CELL CARCINOMA
    ESCUDIER, B
    FARACE, F
    ANGEVIN, E
    TRIEBEL, F
    ANTOUN, S
    LECLERCQ, B
    BRANDELY, M
    ABOUDARAM, A
    NITENBERG, G
    HERCEND, T
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (05) : 724 - 728
  • [3] INTERFERON-ALFA AND VINBLASTINE VERSUS MEDROXYPROGESTERONE ACETATE IN THE TREATMENT OF METASTATIC RENAL-CELL CARCINOMA
    KRIEGMAIR, M
    OBERNEDER, R
    HOFSTETTER, A
    UROLOGY, 1995, 45 (05) : 758 - 762
  • [4] INTERLEUKIN-2 AND INTERFERON IN RENAL-CELL CARCINOMA
    WERSALL, P
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1993, 10 (1-2): : 71 - 76
  • [5] COMBINATION OF CHEMOTHERAPY WITH INTERLEUKIN-2 AND INTERFERON-ALFA FOR THE TREATMENT OF ADVANCED MELANOMA
    BUZAID, AC
    LEGHA, SS
    SEMINARS IN ONCOLOGY, 1994, 21 (06) : 23 - 28
  • [6] TREATMENT OF METASTATIC MELANOMA AND RENAL-CELL CARCINOMA WITH INTERLEUKIN-2
    MANSON, LA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (17): : 1327 - 1327
  • [7] CONCOMITANT ADMINISTRATION OF RECOMBINANT HUMAN INTERLEUKIN-2 AND RECOMBINANT INTERFERON ALFA-2A - AN ACTIVE OUTPATIENT REGIMEN IN METASTATIC RENAL-CELL CARCINOMA
    FIGLIN, RA
    BELLDEGRUN, A
    MOLDAWER, N
    ZEFFREN, J
    DEKERNION, J
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (03) : 414 - 421
  • [8] Treatment of patients with metastatic renal carcinoma with a combination of subcutaneous interleukin-2 and interferon alfa with or without fluorouracil
    Négrier, S
    Caty, A
    Lesimple, T
    Douillard, JY
    Escudier, B
    Rossi, JF
    Viens, P
    Gomez, F
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (24) : 4009 - 4015
  • [9] COMBINATION THERAPY WITH INTERFERON ALFA-2A AND INTERLEUKIN-2 FOR THE TREATMENT OF METASTATIC CANCER
    MARINCOLA, FM
    WHITE, DE
    WISE, AP
    ROSENBERG, SA
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (05) : 1110 - 1122
  • [10] Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma
    Negrier, S
    Escudier, B
    Lasset, C
    Douillard, JY
    Savary, J
    Chevreau, C
    Ravaud, A
    Mercatello, A
    Peny, J
    Mousseau, M
    Philip, T
    Tursz, T
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (18): : 1272 - 1278